miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner

BACKGROUND: Gastric cancer (GC) is a common malignant disease worldwide. Aberrant miRNAs expression contributes to malignant cells behaviour, and in preclinical research, miRNA targeting has shown potential for improving GC therapy. Our present study demonstrated that miR-632 promotes GC progression...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Shi, Ying, Huang, Xiaoxiao, Chen, Guobin, Wang, Ying, Liu, Yuansheng, Xu, Wei, Tang, Shaohui, Guleng, Bayasi, Liu, Jingjing, Ren, Jianlin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6322242/
https://ncbi.nlm.nih.gov/pubmed/30612555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5247-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados